Key Documents
James Swartz
Publications
-
Continued protein synthesis at low [ATP] and [GTP] enables cell adaptation during energy limitation.
Jewett MC,
Miller ML, Chen Y, Swartz JR.
J Bacteriol.
2009;
191
(3):
1083-91
-
Cell-free synthesis of functional aquaporin Z in synthetic liposomes.
Hovijitra NT,
Wuu JJ, Peaker B, Swartz JR.
Biotechnol Bioeng.
2009;
104
(1):
40-9
-
High-level cell-free synthesis yields of proteins containing site-specific non-natural amino acids.
Goerke AR,
Swartz JR.
Biotechnol Bioeng.
2009;
102
(2):
400-16
-
Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferase.
Goerke AR,
Loening AM, Gambhir SS, Swartz JR.
Metab Eng.
2008 May-Jul;
10
(3-4):
187-200
-
Escherichia coli-based cell-free synthesis of virus-like particles.
Bundy BC,
Franciszkowicz MJ, Swartz JR.
Biotechnol Bioeng.
2008;
100
(1):
28-37
-
High yield cell-free production of integral membrane proteins without refolding or detergents.
Wuu JJ,
Swartz JR.
Biochim Biophys Acta.
2008;
1778
(5):
1237-50
-
An integrated cell-free metabolic platform for protein production and synthetic biology.
Jewett MC,
Calhoun KA, Voloshin A, Wuu JJ, Swartz JR.
Mol Syst Biol.
2008;
4
220
-
Development of cell-free protein synthesis platforms for disulfide bonded proteins.
Goerke AR,
Swartz JR.
Biotechnol Bioeng.
2008;
99
(2):
351-67
-
Cell-free synthesis and maturation of [FeFe] hydrogenases.
Boyer ME,
Stapleton JA, Kuchenreuther JM, Wang CW, Swartz JR.
Biotechnol Bioeng.
2008;
99
(1):
59-67
-
Energy systems for ATP regeneration in cell-free protein synthesis reactions.
Calhoun KA,
Swartz JR.
Methods Mol Biol.
2007;
375
3-17
-
Evidence for an additional disulfide reduction pathway in Escherichia coli.
Knapp KG,
Swartz JR.
J Biosci Bioeng.
2007;
103
(4):
373-6
-
Cell-free synthesis of proteins that require disulfide bonds using glucose as an energy source.
Knapp KG,
Goerke AR, Swartz JR.
Biotechnol Bioeng.
2007;
97
(4):
901-8
-
Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.
Kanter G,
Yang J, Voloshin A, Levy S, Swartz JR, Levy R.
Blood.
2007;
109
(8):
3393-9
-
A sequential expression system for high-throughput functional genomic analysis.
Woodrow KA,
Swartz JR.
Proteomics.
2007;
7
(21):
3870-9
-
Simultaneous expression and maturation of the iron-sulfur protein ferredoxin in a cell-free system.
Boyer ME,
Wang CW, Swartz JR.
Biotechnol Bioeng.
2006;
94
(1):
128-38
-
Rapid expression of functional genomic libraries.
Woodrow KA,
Airen IO, Swartz JR.
J Proteome Res.
2006;
5
(12):
3288-300
-
Total amino acid stabilization during cell-free protein synthesis reactions.
Calhoun KA,
Swartz JR.
J Biotechnol.
2006;
123
(2):
193-203
-
Streamlining Escherichia coli S30 extract preparation for economical cell-free protein synthesis.
Liu DV,
Zawada JF, Swartz JR.
Biotechnol Prog.
2005 Mar-Apr;
21
(2):
460-5
-
An economical method for cell-free protein synthesis using glucose and nucleoside monophosphates.
Calhoun KA,
Swartz JR.
Biotechnol Prog.
2005 Jul-Aug;
21
(4):
1146-53
-
Quantitative polysome analysis identifies limitations in bacterial cell-free protein synthesis.
Underwood KA,
Swartz JR, Puglisi JD.
Biotechnol Bioeng.
2005;
91
(4):
425-35
-
Efficient and scalable method for scaling up cell free protein synthesis in batch mode.
Voloshin AM,
Swartz JR.
Biotechnol Bioeng.
2005;
91
(4):
516-21
-
Energizing cell-free protein synthesis with glucose metabolism.
Calhoun KA,
Swartz JR.
Biotechnol Bioeng.
2005;
90
(5):
606-13
-
Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
Yang J,
Kanter G, Voloshin A, Michel-Reydellet N, Velkeen H, Levy R, Swartz JR.
Biotechnol Bioeng.
2005;
89
(5):
503-11
-
Expression of active murine granulocyte-macrophage colony-stimulating factor in an Escherichia coli cell-free system.
Yang J,
Kanter G, Voloshin A, Levy R, Swartz JR.
Biotechnol Prog.
2004 Nov-Dec;
20
(6):
1689-96
-
Affinity purification of lipid vesicles.
Peker B,
Wuu JJ, Swartz JR.
Biotechnol Prog.
2004 Jan-Feb;
20
(1):
262-8
-
Rapid expression and purification of 100 nmol quantities of active protein using cell-free protein synthesis.
Jewett MC,
Swartz JR.
Biotechnol Prog.
2004 Jan-Feb;
20
(1):
102-9
-
Cell-free protein synthesis with prokaryotic combined transcription-translation.
Swartz JR,
Jewett MC, Woodrow KA.
Methods Mol Biol.
2004;
267
169-82
-
Substrate replenishment extends protein synthesis with an in vitro translation system designed to mimic the cytoplasm.
Jewett MC,
Swartz JR.
Biotechnol Bioeng.
2004;
87
(4):
465-72
-
Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis.
Jewett MC,
Swartz JR.
Biotechnol Bioeng.
2004;
86
(1):
19-26
-
Cell-free production of active E. coli thioredoxin reductase and glutathione reductase.
Knapp KG,
Swartz JR.
FEBS Lett.
2004;
559
(1-3):
66-70
-
Efficient production of a bioactive, multiple disulfide-bonded protein using modified extracts of Escherichia coli.
Kim DM,
Swartz JR.
Biotechnol Bioeng.
2004;
85
(2):
122-9
-
Enhancing multiple disulfide bonded protein folding in a cell-free system.
Yin G,
Swartz JR.
Biotechnol Bioeng.
2004;
86
(2):
188-95
-
Regeneration of adenosine triphosphate from glycolytic intermediates for cell-free protein synthesis.
Kim DM,
Swartz JR.
Biotechnol Bioeng.
2001;
74
(4):
309-16
-
Advances in Escherichia coli production of therapeutic proteins.
Swartz JR,
Curr Opin Biotechnol.
2001;
12
(2):
195-201
-
Prolonging cell-free protein synthesis by selective reagent additions.
Kim DM,
Swartz JR.
Biotechnol Prog.
2000 May-Jun;
16
(3):
385-90